HilleVax Management
Management criteria checks 1/4
HilleVax's CEO is Rob Hershberg, appointed in Mar 2020, has a tenure of 4.67 years. total yearly compensation is $9.70M, comprised of 6.6% salary and 93.4% bonuses, including company stock and options. directly owns 1.69% of the company’s shares, worth $1.55M. The average tenure of the management team and the board of directors is 1.8 years and 3.6 years respectively.
Key information
Rob Hershberg
Chief executive officer
US$9.7m
Total compensation
| CEO salary percentage | 6.6% |
| CEO tenure | 4.7yrs |
| CEO ownership | 1.7% |
| Management average tenure | 1.8yrs |
| Board average tenure | 3.6yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$150m |
| Jun 30 2024 | n/a | n/a | -US$156m |
| Mar 31 2024 | n/a | n/a | -US$144m |
| Dec 31 2023 | US$10m | US$636k | -US$124m |
| Sep 30 2023 | n/a | n/a | -US$108m |
| Jun 30 2023 | n/a | n/a | -US$93m |
| Mar 31 2023 | n/a | n/a | -US$119m |
| Dec 31 2022 | US$1m | US$600k | -US$160m |
| Sep 30 2022 | n/a | n/a | -US$176m |
| Jun 30 2022 | n/a | n/a | -US$221m |
| Mar 31 2022 | n/a | n/a | -US$169m |
| Dec 31 2021 | US$611k | US$467k | -US$102m |
| Sep 30 2021 | n/a | n/a | -US$66m |
| Dec 31 2020 | US$466k | US$388k | -US$2m |
Compensation vs Market: Rob's total compensation ($USD9.70M) is above average for companies of similar size in the US market ($USD646.00K).
Compensation vs Earnings: Rob's compensation has increased whilst the company is unprofitable.
CEO
Rob Hershberg (62 yo)
4.7yrs
Tenure
US$9,697,495
Compensation
Dr. Robert M. Hershberg, PhD, MD, also known as Rob, is Co-Founder & Executive Chairman at Cajal Neuroscience, Inc. He serves as Member of Scientific Advisory Board at Danaher Corporation. He also serves a...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 4.7yrs | US$9.70m | 1.69% $ 1.6m | |
| Co-Founder | less than a year | US$4.08m | 1.34% $ 1.2m | |
| Chief Medical Officer | 3.7yrs | US$2.84m | 0.26% $ 235.4k | |
| CFO & Treasurer | 1.8yrs | no data | 0.017% $ 15.6k | |
| Chief Operating Officer | less than a year | no data | 0.0026% $ 2.4k | |
| Chief Technology Officer | 1.8yrs | no data | no data | |
| General Counsel | no data | no data | no data | |
| Senior Vice President of Regulatory Affairs | 1.8yrs | no data | no data |
1.8yrs
Average Tenure
52yo
Average Age
Experienced Management: HLVX's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 4.7yrs | US$9.70m | 1.69% $ 1.6m | |
| Co-Founder | 2.9yrs | US$4.08m | 1.34% $ 1.2m | |
| Independent Director | 4.7yrs | US$367.11k | 0.098% $ 90.7k | |
| Independent Director | 3.6yrs | US$375.11k | 0.087% $ 80.3k | |
| Independent Director | 3.3yrs | US$355.11k | 0% $ 0 | |
| Independent Director | 3.6yrs | US$365.93k | 0.087% $ 80.3k | |
| Independent Director | 3.8yrs | US$353.11k | 0.087% $ 80.3k | |
| Independent Director | 1.5yrs | US$555.03k | 0% $ 0 | |
| Director | 2.8yrs | no data | no data |
3.6yrs
Average Tenure
62yo
Average Age
Experienced Board: HLVX's board of directors are considered experienced (3.6 years average tenure).